Topical Simvastatin for Treating Infantile Hemangioma
Conditions: Hemangioma Skin Interventions: Drug: 5% simvastatin ointment Sponsors: Joyce Teng; Stanford University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 22, 2024 Category: Research Source Type: clinical trials
Study on Treatment Decision-Making and Prognostic Follow-Up for Untreated Cerebral Cavernous Malformations
Conditions: Hemangioma, Cavernous, Central Nervous System Sponsors: Beijing Tiantan Hospital; RenJi Hospital; Beijing Chao Yang Hospital; Beijing Friendship Hospital; Guangzhou Red Cross Hospital; Affiliated Hospital of Guangdong Medical University; Shanxi Provincipal People ' s Hospital; Qilu Hospital of Shandong University; Central South University; First Affiliated Hospital of Harbin Medical University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 22, 2024 Category: Research Source Type: clinical trials
Application of Perioperative Remote Ischemic Conditioning in Patients Undergoing Hepatectomy
Conditions: Hepatic Hemangioma; Liver Cancer; Hepatolithiasis; Hepatectomy Interventions: Device: Sham-Remote Ischemic Conditioning; Device: Remote Ischemic Conditioning Once Daily; Device: Remote Ischemic Conditioning Twice Daily Sponsors: The Second Affiliated Hospital of Chongqing Medical University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 14, 2023 Category: Research Source Type: clinical trials
Efficacy of Intralesional Bleomycin Alone and in Combination With Dexamethasone in Infantile Haemangiomas
Conditions: Comparison of Efficacy of Sclerotherapy in Infantile Hemangioma Interventions: Drug: Comparison of intralesional injection of bleomycin alone and combined with injection dexamethasone Sponsors: King Edward Medical University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 12, 2023 Category: Research Source Type: clinical trials
Assessing the Impact of Dosage Frequency of Propranolol on Sleep Patterns in Patients With Infantile Hemangiomas
Condition: Infantile Hemangioma Interventions: Drug: Propranolol three times a day; Drug: Propranolol twice a day; Drug: Timolol Sponsor: The University of Texas Health Science Center, Houston Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 29, 2022 Category: Research Source Type: clinical trials
